Faecalibacterium prausnitzii

Butyrate Production and Barrier Protection#

Produces butyrate as its primary fermentation end-product. Butyrate is the preferred energy source for colonocytes and the most potent SCFA for. Strengthening tight junction protein expression (ZO-1, occludin, claudin-1).

Suppressing NF-kB-mediated Metal-Driven Inflammation via HDAC inhibition and GPR109A signaling.

Promoting regulatory T cell (Treg) differentiation—critical for immune tolerance. Maintaining epithelial oxygen consumption, preserving the anaerobic luminal environment that favors beneficial obligate anaerobes over facultative pathobionts. Butyrate production depends on iron-sulfur cluster enzymes in the butyrate synthesis pathway, connecting this commensal's function indirectly to Iron availability.

Arsenic#

The landmark Coryell et al. (2018) study demonstrated that F. prausnitzii is sufficient for at least partial protection against acute arsenic toxicity.^{[1]The gut microbiome is required for full protection against acute arsenic toxicity in mouse modelsCoryell M, McAlpine M, Pinkham NV et al. · 2018Open reference 1 ↓}

Germ-free mice mono-associated with E. coli alone died rapidly from arsenic exposure; bi-colonization with E. coli + F. prausnitzii significantly extended survival. F. prausnitzii abundance was consistently associated with survival across human stool transplant experiments.

The Gut Microbiome is required for full arsenic protection; antibiotic-treated mice accumulate more arsenic in organs and excrete less in feces.

Cadmium and Lead#

Depleted by cadmium and lead exposure in multiple mouse models.^{[2]Gut Microbiota: A Target for Heavy Metal Toxicity and a Probiotic Protective StrategyHui Duan, Leilei Yu, Fengwei Tian et al. · 2020Open reference 2 ↓} Its loss under cadmium (Cd)/lead (Pb) exposure reduces butyrate production, compromising barrier integrity and increasing systemic metal absorption—a vicious cycle.

Classified as a next-generation probiotic for metal detoxification alongside Akkermansia muciniphila.^{[2]Gut Microbiota: A Target for Heavy Metal Toxicity and a Probiotic Protective StrategyHui Duan, Leilei Yu, Fengwei Tian et al. · 2020Open reference 2 ↓}

Depletion Across Disease States#

F. prausnitzii depletion is among the most reproducible microbiome findings in disease. IBD (Crohn's disease): dramatically reduced; inversely correlated with disease severity and relapse risk. The strongest single-organism biomarker for Crohn's remission.

Multiple sclerosis: decreased in MS patients; negatively associated with TNF-alpha levels.^{[3]Feeding the gut microbiome: impact on multiple sclerosisMatteo Bronzini, Alessandro Maglione, Rachele Rosso et al. · 2023Open reference 3 ↓[4]Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy ControlsAnna Olsson, Stefan Gustavsen, Thao Duy Nguyen et al. · 2021Open reference 4 ↓[5]Short-chain fatty acids and intestinal inflammation in multiple sclerosis: modulation of female susceptibility by microbial products?Anouck Becker, Mosab Abuazab, Andreas Schwiertz et al. · 2021Open reference 5 ↓}

Parkinson's disease: reduced abundance linked to decreased butyrate and increased gut permeability, potentially facilitating alpha-synuclein propagation via the Gut-Brain Axis.^{[6]Microbial Metallomics and Parkinson's Disease: A Unified Metal-Driven Framework Linking Ferroptosis, Dysbiosis, and alpha-Synuclein PathologyKaren Pendergrass · 2025Open reference 6 ↓[7]Aho 2021 -- Relationships of Gut Microbiota, Short-Chain Fatty Acids, Inflammation, and the Gut Barrier in Parkinson's DiseaseVelma T E Aho, Madelyn C Houser, Pedro A B Pereira et al. · 2021Open reference 7 ↓[8]Tan 2022 -- The Role of Short-Chain Fatty Acids in Health and DiseaseJing Tan, Craig McKenzie, Maria Potamitis et al. · 2023Open reference 8 ↓}

Chronic kidney disease: depleted, contributing to uremic toxin accumulation; butyrate-producing taxa are reduced with disease progression.^{[9]Gao 2021 — Butyrate Producing Microbiota Are Reduced in Chronic Kidney DiseasesBei Gao, Adarsh Jose, Norma Alonzo-Palma et al. · 2021Open reference 9 ↓[10]Gut Microbial Metabolites SCFAs and Chronic Kidney DiseaseMeng He, Wenqian Wei, Yichen Zhang et al. · 2024Open reference 10 ↓}

Type 2 diabetes: inversely correlated with HbA1c and fasting glucose; fiber interventions that restore F. prausnitzii improve glycemic control.^{[11]Salamone 2021 — The Relationship between Gut Microbiota, Short-Chain Fatty Acids and Type 2 Diabetes: The Role of Dietary FibreDominic Salamone, Angela Albarosa Rivellese, Claudia Vetrani · 2021Open reference 11 ↓[12]SCFA 2020 — Dietary Fiber and Short-Chain Fatty Acids in Type 2 DiabetesVarious · 2020Open reference 12 ↓}

Autism spectrum disorder: reduced; butyrate-producer depletion is a recurring ASD signature and Faecalibacterium hominis-derived indole signaling via AhR is under active study.^{[13]Yu 2025 — The Gut Commensal Faecalibacterium hominis Attenuates Indole-AhR Signaling and Restores ASD-Like Behaviors with BTBR MiceYou Yu, Yujing Wang, Jie Zhang et al. · 2025Open reference 13 ↓[14]Liu 2019 — Altered Gut Microbiota and SCFAs in Chinese ASD ChildrenSimeng Liu, Enyao Li, Zhenyu Sun et al. · 2019Open reference 14 ↓}

Schizophrenia: altered SCFA producers including F. prausnitzii are linked to ultra-high-risk state and symptom severity.^{[15]Peng 2022 -- Short-chain fatty acids in patients with schizophrenia and ultra-high risk populationHuiqing Peng, Lijun Ouyang, David Li et al. · 2022Open reference 15 ↓[16]Yu 2024 -- A cross-section study of the comparison of plasma inflammatory cytokines and short-chain fatty acid in patients with depression and schizophreniaHuan Yu, Rui Li, Xue-jun Liang et al. · 2024Open reference 16 ↓}

Graves' disease: negatively correlated with FT3, FT4, and TRAb but positively correlated with TSH; berberine supplementation increased F. prausnitzii alongside thyroid function recovery.^{[17]Han et al. 2022 — The Potential Prebiotic Berberine Combined With Methimazole Improved the Therapeutic Effect of Graves' Disease Patients Through Regulating the Intestinal MicrobiomeHan Z, Cen C, Ou Q et al. · 2022Open reference 17 ↓}

Obesity: inversely correlated with BMI and metabolic inflammation.^{[18]Heavy Metals, Microbial Metallomics, and the US Obesity Epidemic: A Mechanistic Examination of a Population-Level Metabolic DisruptionKaren Pendergrass · 2026Open reference 18 ↓} Colorectal cancer: reduced; butyrate loss may diminish anti-tumorigenic HDAC inhibition.^{[19]Short-chain fatty acids in cancer pathogenesisMark A. Feitelson, Alla Arzumanyan, Arvin Medhat et al. · 2023Open reference 19 ↓[20]Participation of short-chain fatty acids and their receptors in gut inflammation and colon cancerMaria Daniella Carretta, John Quiroga, Rodrigo Lopez et al. · 2021Open reference 20 ↓}

Post-COVID / Long COVID: depletion of SCFA producers including F. prausnitzii associated with altered immune response.^{[21]Didenko et al 2025 — Intestinal Microbiota and Short-Chain Fatty Acids in Patients with Post-COVID Immune ResponseV.I. Didenko, I.A. Klenina, O.M. Tatarchuk et al. · 2025Open reference 21 ↓}